Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07599904 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

Study acronym: RECANOVA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 2 to 3v6
  2. Start date changed from estimate of Jul 2026 to Jul 13, 2026v5
  3. Study sites: 1 to 2
    • Start date: Jun 2026 to Jul 2026
    • Interventions: Device: Mechanical Thrombectomy (Procedure) to Mechanical Thrombectomy (Device)
    v4
  4. Recruitment opened
    • Start date: May 2026 to Jun 2026
    • Site details revised
    v3
  5. Study sites: 0 to 1v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Post-Market Registry
Trial Details
NCT Number NCT07599904
Lead Sponsor Medtronic Neurovascular Clinical Affairs
Conditions
(from sponsor)		 Acute Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov